Lithium Carbonate ER Tablets and Sodium Phenylbutyrate Powder
Determining the interaction of Lithium Carbonate ER Tablets and Sodium Phenylbutyrate Powder and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: sodium phenylbutyrate
Brand name: Buphenyl
Synonyms: Sodium phenylbutyrate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Carbonate ER Tablets-Sodium Phenylbutyrate Tablets
- Lithium Carbonate ER Tablets-Sodium phosphate dibasic and sodium phosphate monobasic
- Lithium Carbonate ER Tablets-Sodium phosphate dibasic and sodium phosphate monobasic Rectal
- Lithium Carbonate ER Tablets-Sodium phosphate p 32 Intravenous
- Lithium Carbonate ER Tablets-Sodium Phosphates
- Lithium Carbonate ER Tablets-Sodium Phosphates Enema
- Sodium Phenylbutyrate Powder-Lithium Carbonate Tablets
- Sodium Phenylbutyrate Powder-Lithium Citrate Syrup
- Sodium Phenylbutyrate Powder-Lithium Controlled-Release and Extended-Release Tablets
- Sodium Phenylbutyrate Powder-Lithium ER
- Sodium Phenylbutyrate Powder-Lithium Oral Solution
- Sodium Phenylbutyrate Powder-Lithium Salts